{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:23:18Z","timestamp":1779193398917,"version":"3.51.4"},"reference-count":70,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofsubstanceabusetreatment.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Abuse Treatment"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.jsat.2021.108644","type":"journal-article","created":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T11:45:29Z","timestamp":1635162329000},"page":"108644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment"],"prefix":"10.1016","volume":"135","author":[{"given":"Monica Rivera","family":"Mindt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly","family":"Coulehan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maral","family":"Aghvinian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Travis M.","family":"Scott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James Patrick","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chinazo O.","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franchesca","family":"Arias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia H.","family":"Arnsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0005","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jaac.2010.10.005","article-title":"Disparities in treatment for substance use disorders and co-occurring disorders for ethnic\/racial minority youth","volume":"50","author":"Alegria","year":"2011","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"6","key":"10.1016\/j.jsat.2021.108644_bb0010","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10461-010-9684-1","article-title":"Neurocognitive impairment and HIV risk factors: A reciprocal relationship","volume":"14","author":"Anand","year":"2010","journal-title":"AIDS and Behavior"},{"issue":"11","key":"10.1016\/j.jsat.2021.108644_bb0015","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.addbeh.2010.06.018","article-title":"Gender and prescription opioids: Findings from the National Survey on drug use and health","volume":"35","author":"Back","year":"2010","journal-title":"Addictive Behaviors"},{"issue":"5","key":"10.1016\/j.jsat.2021.108644_bb0020","doi-asserted-by":"crossref","first-page":"313","DOI":"10.3109\/00952990.2011.596982","article-title":"Comparative profiles of men and women with opioid dependence: Results from a national multisite effectiveness trial","volume":"37","author":"Back","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2021.108644_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.neubiorev.2016.11.008","article-title":"Neuropsychological functioning and chronic methadone use: A systematic review and meta-analysis","volume":"73","author":"Baldacchino","year":"2017","journal-title":"Neuroscience & Biobehavioral Reviews"},{"issue":"6","key":"10.1016\/j.jsat.2021.108644_bb0030","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1017\/S0033291714002189","article-title":"Impulsivity and opioid drugs: Differential effects of heroin, methadone and prescribed analgesic medication","volume":"45","author":"Baldacchino","year":"2015","journal-title":"Psychological Medicine"},{"issue":"7","key":"10.1016\/j.jsat.2021.108644_bb0035","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1017\/S0033291718003318","article-title":"Profiles of visuospatial memory dysfunction in opioid-exposed and dependent populations","volume":"49","author":"Baldacchino","year":"2018","journal-title":"Psychological Medicine"},{"key":"10.1016\/j.jsat.2021.108644_bb0040","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/2046-4053-3-45","article-title":"Sex differences in outcomes of methadone maintenance treatment for opioid addiction: A systematic review protocol","volume":"3","author":"Bawor","year":"2014","journal-title":"Systematic Reviews"},{"issue":"4","key":"10.1016\/j.jsat.2021.108644_bb0045","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1037\/1064-1297.3.4.477","article-title":"Buprenorphine treatment of opioid dependence: A review","volume":"3","author":"Bickel","year":"1995","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.jsat.2021.108644_bb0050","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.drugalcdep.2012.04.004","article-title":"Response inhibition and psychomotor speed during methadone maintenance: Impact of treatment duration, dose, and sleep deprivation","volume":"125","author":"Bracken","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108644_bb0060","doi-asserted-by":"crossref","first-page":"9708","DOI":"10.1038\/srep09708","article-title":"Low-dose add-on memantine treatment may improve cognitive performance and self-reported health conditions in opioid-dependent patients undergoing methadone-maintenance-therapy","volume":"5","author":"Chang","year":"2015","journal-title":"Scientific Reports"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1037\/0033-2909.112.1.155","article-title":"A power primer","volume":"112","author":"Cohen","year":"1992","journal-title":"Psychological Bulletin"},{"issue":"1\u20133","key":"10.1016\/j.jsat.2021.108644_bb0070","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.drugalcdep.2010.01.012","article-title":"Attentional bias, inhibitory control and acute stress in current and former opiate addicts","volume":"109","author":"Constantinou","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.jsat.2021.108644_bb0075","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/j.jaac.2011.09.006","article-title":"Racial\/ethnic differences in treatment for substance use disorders among US adolescents","volume":"50","author":"Cummings","year":"2011","journal-title":"Journal of the American Academy of Child & Adolescent Psychiatry"},{"issue":"5","key":"10.1016\/j.jsat.2021.108644_bb0080","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1046\/j.1360-0443.1999.9456654.x","article-title":"Additional methadone increases craving for heroin: A double-blind, placebo-controlled study of chronic opiate users receiving methadone substitution treatment","volume":"94","author":"Curran","year":"1999","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0085","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s002130000628","article-title":"Effects of methadone on cognition, mood and craving in detoxifying opiate addicts: A dose-response study","volume":"154","author":"Curran","year":"2001","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.jsat.2021.108644_bb0090","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.drugalcdep.2012.05.032","article-title":"Comparative patterns of cognitive performance amongst opioid maintenance patients, abstinent opioid users and non-opioid users","volume":"126","author":"Darke","year":"2012","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2021.108644_bb0095","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1046\/j.1360-0443.2000.9556874.x","article-title":"Cognitive impairment among methadone maintenance patients","volume":"95","author":"Darke","year":"2000","journal-title":"Addiction"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0376-8716(02)00012-1","article-title":"Neuropsychological deficits and opiate abuse","volume":"67","author":"Davis","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0105","first-page":"31","article-title":"Buprenorphine maintenance for opioid dependence in public sector healthcare: Benefits and barriers","volume":"1","author":"Duncan","year":"2015","journal-title":"Journal of Addiction Medicine and Therapeutic Science"},{"issue":"6","key":"10.1016\/j.jsat.2021.108644_bb0110","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1037\/a0021559","article-title":"A comparative study of drug-related attentional bias: Evidence from Iran","volume":"18","author":"Fadardi","year":"2010","journal-title":"Experimental and Clinical Psychopharmacology"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1080\/08897077.2013.819828","article-title":"A comparison of characteristics and outcomes of opioid-dependent patients initiating office-based buprenorphine or methadone maintenance treatment","volume":"35","author":"Fingerhood","year":"2014","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.jsat.2021.108644_bb0120","doi-asserted-by":"crossref","first-page":"e203711","DOI":"10.1001\/jamanetworkopen.2020.3711","article-title":"Association of racial\/ethnic segregation with treatment capacity for opioid use disorder in counties in the U.S","volume":"3","author":"Goedel","year":"2020","journal-title":"JAMA Network Open"},{"issue":"3","key":"10.1016\/j.jsat.2021.108644_bb0125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s11065-007-9041-y","article-title":"Neuropsychological consequences of opiate use","volume":"17","author":"Gruber","year":"2007","journal-title":"Neuropsychology Review"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0130","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1037\/1064-1297.14.2.157","article-title":"Methadone maintenance improves cognitive performance after two months of treatment","volume":"14","author":"Gruber","year":"2006","journal-title":"Experimental and Clinical Psychopharmacology"},{"key":"10.1016\/j.jsat.2021.108644_bb0135","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2016.03.028","article-title":"Buprenorphine and methadone treatment for opioid dependence by income, ethnicity and race of neighborhoods in New York City","volume":"164","author":"Hansen","year":"2016","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2021.108644_bb0140","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11414-013-9341-3","article-title":"Variation in use of buprenorphine and methadone treatment by racial, ethnic, and income characteristics of residential social areas in New York City","volume":"40","author":"Hansen","year":"2013","journal-title":"The Journal of Behavioral Health Services & Research"},{"issue":"3","key":"10.1016\/j.jsat.2021.108644_bb0145","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.drugalcdep.2004.02.001","article-title":"Opioid-, cannabis-and alcohol-dependent women show more rapid progression to substance abuse treatment","volume":"74","author":"Hernandez-Avila","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"5","key":"10.1016\/j.jsat.2021.108644_bb0150","first-page":"35","article-title":"Comparing neurocognitive function in individuals receiving chronic methadone or buprenorphine for the treatment of opioid dependence: A systematic review","volume":"20","author":"Hill","year":"2018","journal-title":"Heroin Addiction and Related Clinical Problems."},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0155","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/sj.bjp.0704280","article-title":"HS-599: A novel long acting opioid analgesic does not induce place-preference in rats","volume":"134","author":"Lattanzi","year":"2001","journal-title":"British Journal of Pharmacology"},{"key":"10.1016\/j.jsat.2021.108644_bb0160","series-title":"Neuropsychological assessment","author":"Lezak","year":"2012"},{"issue":"4","key":"10.1016\/j.jsat.2021.108644_bb0165","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0094589","article-title":"Cognitive control in opioid dependence and methadone maintenance treatment","volume":"9","author":"Liao","year":"2014","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.jsat.2021.108644_bb0170","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.jclinepi.2009.06.006","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: Explanation and elaboration","volume":"62","author":"Liberati","year":"2009","journal-title":"Journal of Clinical Epidemiology"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0175","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.pscychresns.2011.05.009","article-title":"Structural deficits in the emotion circuit and cerebellum are associated with depression, anxiety and cognitive dysfunction in methadone maintenance patients: A voxel-based morphometric study","volume":"201","author":"Lin","year":"2012","journal-title":"Psychiatry Research: Neuroimaging"},{"issue":"5","key":"10.1016\/j.jsat.2021.108644_bb0180","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1080\/00952990802308239","article-title":"Neuropsychological functioning of opiate-dependent patients: A nonrandomized comparison of patients preferring either buprenorphine or methadone maintenance treatment","volume":"34","author":"Loeber","year":"2008","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.jsat.2021.108644_bb0185","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0190","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jsat.2012.12.007","article-title":"Gender differences in a clinical trial for prescription opioid dependence","volume":"45","author":"McHugh","year":"2013","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"6","key":"10.1016\/j.jsat.2021.108644_bb0195","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/00002030-199006000-00011","article-title":"A prospective comparison of neuropsychologic function in HIV-seropositive and seronegative methadone-maintained patients","volume":"4","author":"McKegney","year":"1990","journal-title":"AIDS"},{"issue":"7","key":"10.1016\/j.jsat.2021.108644_bb0200","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/hup.1050","article-title":"Neuropsychological functioning in buprenorphine maintained patients versus abstinent heroin abusers on naltrexone hydrochloride therapy","volume":"24","author":"Messinis","year":"2009","journal-title":"Human Psychopharmacology: Clinical and Experimental"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0205","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.drugalcdep.2003.12.008","article-title":"A dose\u2013effect study of repeated administration of buprenorphine\/naloxone on performance in opioid-dependent volunteers","volume":"74","author":"Mintzer","year":"2004","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0210","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0376-8716(02)00013-3","article-title":"Cognitive impairment in methadone maintenance patients","volume":"67","author":"Mintzer","year":"2002","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.jsat.2021.108644_bb0215","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","first-page":"521","article-title":"Opioid analgesics and antagonists","author":"Pasternak Reisine","year":"1996"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0220","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.drugalcdep.2005.11.008","article-title":"Impaired decision-making in opiate-dependent subjects: Effect of pharmacological therapies","volume":"83","author":"Pirastu","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"3","key":"10.1016\/j.jsat.2021.108644_bb0225","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.drugalcdep.2006.02.006","article-title":"Neuropsychological functioning in opiate-dependent subjects receiving and following methadone maintenance treatment","volume":"84","author":"Prosser","year":"2006","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0230","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1148\/radiol.11102466","article-title":"Regional homogeneity changes in heroin-dependent individuals: Resting-state functional MR imaging study","volume":"261","author":"Qiu","year":"2011","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0235","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6904-7-5","article-title":"Methadone vs. buprenorphine\/naloxone during early opioid substitution treatment: A naturalistic comparison of cognitive performance relative to healthy controls","volume":"7","author":"Rapeli","year":"2007","journal-title":"BMC Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0240","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1747-597X-4-6","article-title":"Memory function in opioid-dependent patients treated with methadone or buprenorphine along with benzodiazepine: Longitudinal change in comparison to healthy individuals","volume":"4","author":"Rapeli","year":"2009","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0245","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1472-6904-11-13","article-title":"Cognitive functioning in opioid-dependent patients treated with buprenorphine, methadone, and other psychoactive medications: Stability and correlates","volume":"11","author":"Rapeli","year":"2011","journal-title":"BMC Clinical Pharmacology"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0250","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13011-017-0133-2","article-title":"Neuropsychological function is improved among opioid dependent adults who adhere to opiate agonist treatment with buprenorphine-naloxone: A preliminary study","volume":"12","author":"Scott","year":"2017","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"6","key":"10.1016\/j.jsat.2021.108644_bb0255","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/0163-8343(93)90001-5","article-title":"A prospective four-year follow-up of neuropsychological function in HIV seropositive and seronegative methadone-maintained patients","volume":"15","author":"Silberstein","year":"1993","journal-title":"General Hospital Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0260","doi-asserted-by":"crossref","first-page":"41","DOI":"10.5055\/jom.2008.0007","article-title":"Effect of buprenorphine on psychomotor functions in patients on buprenorphine maintenance","volume":"4","author":"Singhal","year":"2008","journal-title":"Journal of Opioid Management"},{"issue":"5","key":"10.1016\/j.jsat.2021.108644_bb0265","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1097\/01.jcp.0000178417.60426.60","article-title":"Less impairment on one portion of a driving-relevant psychomotor battery in buprenorphine-maintained than in methadone-maintained patients: Results of a randomized clinical trial","volume":"25","author":"Soyka","year":"2005","journal-title":"Journal of Clinical Psychopharmacology"},{"issue":"6","key":"10.1016\/j.jsat.2021.108644_bb0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.3109\/00952990.2011.600381","article-title":"A comparison of cognitive function in patients under maintenance treatment with heroin, methadone, or buprenorphine and healthy controls: An open pilot study","volume":"37","author":"Soyka","year":"2011","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"issue":"2\u20132","key":"10.1016\/j.jsat.2021.108644_bb0275","doi-asserted-by":"crossref","first-page":"400","DOI":"10.3109\/15622970902995604","article-title":"Cognitive function in short-and long-term substitution treatment: Are there differences?","volume":"11","author":"Soyka","year":"2010","journal-title":"The World Journal of Biological Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0280","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1159\/000019004","article-title":"Cognitive-motor performance of methadone-maintained patients","volume":"6","author":"Specka","year":"2000","journal-title":"European Addiction Research"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0285","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1196\/annals.1432.008","article-title":"Addiction and cognitive functions","volume":"1139","author":"Spiga","year":"2008","journal-title":"Annals of the New York Academy of Sciences"},{"issue":"4","key":"10.1016\/j.jsat.2021.108644_bb0290","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08897077.2018.1449166","article-title":"A population-based examination of trends and disparities in medication treatment for opioid use disorders among medicaid enrollees","volume":"39","author":"Stein","year":"2018","journal-title":"Substance Abuse"},{"key":"10.1016\/j.jsat.2021.108644_bb0295","author":"Strauss","year":"2006"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0300","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.drugalcdep.2004.12.008","article-title":"The practice of office-based buprenorphine treatment of opioid dependence: Is it associated with new patients entering into treatment?","volume":"79","author":"Sullivan","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0305","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1111\/j.1360-0443.2007.02056.x","article-title":"Gender and non-medical use of prescription opioids: Results from a national US survey","volume":"103","author":"Tetrault","year":"2008","journal-title":"Addiction"},{"issue":"7","key":"10.1016\/j.jsat.2021.108644_bb0310","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1002\/phar.1958","volume":"37","author":"Tran","year":"2017","journal-title":"Pharmacotherapy: The journal of human pharmacology and drugTherapy"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0315","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/10550881003684814","article-title":"Gender issues in the pharmacotherapy of opioid-addicted women: Buprenorphine","volume":"29","author":"Unger","year":"2010","journal-title":"Journal of Addictive Diseases"},{"key":"10.1016\/j.jsat.2021.108644_bb9000","series-title":"World Drug Report 2019","author":"United Nations Office on Drugs and Crime","year":"2019"},{"issue":"3","key":"10.1016\/j.jsat.2021.108644_bb0325","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.drugalcdep.2004.11.006","article-title":"Neuropsychological functioning in methadone maintenance patients versus abstinent heroin abusers","volume":"78","author":"Verdejo","year":"2005","journal-title":"Drug and Alcohol Dependence"},{"issue":"8","key":"10.1016\/j.jsat.2021.108644_bb0330","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1177\/0269881114538541","article-title":"Neuropsychological performance of methadone-maintained opiate users","volume":"28","author":"Wang","year":"2014","journal-title":"Journal of Psychopharmacology"},{"key":"10.1016\/j.jsat.2021.108644_bb0335","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.drugalcdep.2018.06.024","article-title":"Correlation of cytokines, BDNF levels, and memory function in patients with opioid use disorder undergoing methadone maintenance treatment","volume":"191","author":"Wang","year":"2018","journal-title":"Drug and Alcohol Dependence"},{"issue":"12","key":"10.1016\/j.jsat.2021.108644_bb0340","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1176\/appi.ajp.158.12.2027","article-title":"Ethnic disparities in unmet need for alcoholism, drug abuse, and mental health care","volume":"158","author":"Wells","year":"2001","journal-title":"American Journal of Psychiatry"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0345","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4103\/0976-3147.91934","article-title":"Buprenorphine vs methadone treatment: A review of evidence in both developed and developing worlds","volume":"3","author":"Whelan","year":"2012","journal-title":"Journal of Neurosciences in Rural Practice"},{"issue":"2","key":"10.1016\/j.jsat.2021.108644_bb0350","first-page":"e1","article-title":"The opioid epidemic in the U.S. Emergency medicine","volume":"34","author":"Wilkerson","year":"2016","journal-title":"Clinics"},{"issue":"1","key":"10.1016\/j.jsat.2021.108644_bb0355","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0022-3565(24)37186-1","article-title":"Dopamine release in the nucleus accumbens during heroin self-administration is modulated by kappa opioid receptors: An in vivo fast-cyclic voltammetry study","volume":"284","author":"Xi","year":"1998","journal-title":"Journal of Pharmacology and Experimental Therapeutics"}],"container-title":["Journal of Substance Abuse Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221003706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740547221003706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T19:55:24Z","timestamp":1760039724000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740547221003706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":70,"alternative-id":["S0740547221003706"],"URL":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108644","relation":{},"ISSN":["0740-5472"],"issn-type":[{"value":"0740-5472","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Abuse Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsat.2021.108644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"108644"}}